Interaction of Ca2+ and protein phosphorylation in the rabbit platelet release reaction

The Journal of Clinical Investigation
R M Lyons, J O Shaw

Abstract

Ca2+ flux and protein phosphorylation have been implicated as playing an important role in the induction of the platelet release reaction. However, the interactions between Ca2+, protein phosphorylation, and the release reaction have been difficult to study because secretion in human platelets is independent of extracellular Ca2+. Thus, we studied rabbit platelets, which, unlike human platelets, require extracellular Ca2+ for serotonin release to occur. Thrombin, basophil platelet-activating factor (PAF), or ionophore A23187 treatment of intact 32PO43--loaded rabbit platelets resulted in a 200-400% increase in phosphorylation of P7P and P9P, respectively. These peptides were similar in all respects to the peptides phosphorylated in thrombin-treated human platelets. When Ca2+ was replaced in the medium by EGTA, (a) thrombin- and PAF-induced rabbit platelet [3H]serotonin release was inhibited by 60-75%, whereas ionophore-induced release was blocked completely; (b) thrombin-, PAF-, or ionophore-induced P9P phosphorylation was inhibited by 60%; and (c) ionophore-induced P7P phosphorylation was decreased by 60%, whereas that caused by thrombin or PAF was decreased by only 20%. At 0.25-0.5 U/ml of thrombin, phosphorylation preceded [...Continue Reading

References

Apr 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·D R Hathaway, R S Adelstein
Jan 1, 1975·Annual Review of Biochemistry·C S Rubin, O M Rosen
Oct 1, 1975·The Journal of Clinical Investigation·R M LyonsP W Majerus
Aug 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J M MarcumA R Means
Dec 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·G DreyfussE R Blout
May 1, 1978·Experimental Cell Research·A M MalkinsonJ E Foker
Oct 18, 1976·Biochemical and Biophysical Research Communications·I F CharoT C Detwiler
Jun 17, 1976·Biochimica Et Biophysica Acta·L S Robblee, D Sherpro
May 29, 1975·Nature·J L Costa, D L Murphy
Jul 1, 1970·British Journal of Haematology·N G ArdlieJ F Mustard

❮ Previous
Next ❯

Citations

Jul 31, 1985·European Journal of Pharmacology·T J ResinkF R Bühler
Jan 1, 1982·Pharmacology & Therapeutics·N G Ardlie
Jan 1, 1994·Pharmacology & Therapeutics·P Sargeant, S O Sage
Sep 14, 1984·Biochimica Et Biophysica Acta·K IritaS Minakami
Aug 15, 1995·European Journal of Pharmacology·R E CatalánE Garde
Oct 1, 1984·Journal of Ultrastructure Research·K TanakaN Shibata
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·S PontremoliB L Horecker
Jan 1, 1981·Vox Sanguinis·H Holmsen
Jan 1, 1983·Annals of the New York Academy of Sciences·G C WhiteK M Brinkhous
Jan 1, 1984·Journal of Receptor Research·T J Resink, F R Bühler
Jan 1, 1980·Annals of the New York Academy of Sciences·P Y WongW Y Cheung
Oct 15, 1986·Biochemical and Biophysical Research Communications·M SaitohH Hidaka
Oct 30, 1981·Biochemical and Biophysical Research Communications·T C LeeF Snyder
Nov 30, 1984·Biochemical and Biophysical Research Communications·S Kawamoto, H Hidaka
Dec 15, 1986·Biochemical and Biophysical Research Communications·D P Dimitrov, F R Bühler
Oct 1, 1986·Journal of Ultrastructure and Molecular Structure Research·K TanakaT Onji

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.